Eli Lilly shares hit a new record high Tuesday after IPO stock Kailera posted lackluster test results for its obesity drug.
GLOBAL — Eli Lilly shares hit a new record high Tuesday after IPO stock Kailera posted lackluster test results for its obesity drug.
Image source: Investor's Business Daily
This report draws on reporting from Investor's Business Daily. DOCFLiX Desk has verified and adapted this report with additional context for our readers.
Read Original Story ↗